Skip to content

Halozyme Therapeutics, Inc.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Halozyme Appoints Dannielle Appelhans to Board of Directors

    Halozyme Therapeutics, Inc. announced the election of Dannielle Appelhans to its Board of Directors on August 18, 2026. Appelhans brings more than 20 years of executive leadership in biotechnology and pharmaceuticals, including operations, manufacturing, and supply chain expertise.